AnaptysBio Inc. (ANAB)
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 45.65 0.00%
ANAB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.36B
- Forward P/E
- 9.01
- EPS (TTM)
- -$0.96
- Dividend yield
- None
- 52-week range
- 20.18 – 72.36
- Day range
- 45.62 – 47.39
- Volume / Avg
- 766.52K / 569.55K
- Beta
- —
- Shares outstanding
- 29.90M
- Next earnings
- Nov 3, 2026
52-week range
ANAB stock today
On Oct 7, ANAB ended the session at $45.65, shedding $2.24 (4.68%), versus the S&P 500's 0.22% decline. At this level, ANAB sits in the middle of its 52-week range of $20.18 to $72.36: 36.9% below the high and 126.2% above the low. AnaptysBio has posted a net loss over the last twelve months (EPS of -$0.96), so its P/E ratio is not meaningful.
AnaptysBio's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About AnaptysBio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2017
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $0.41
AnaptysBio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TYRATyra Biosciences Inc. | 20.39 | +0.74% | $1.40B | vs ANAB |
| AAPGAscentage Pharma Group International American Depository Shares | 14.94 | -7.15% | $1.40B | vs ANAB |
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs ANAB |
| GHRSGH Research PLC | 21.06 | -2.14% | $1.45B | vs ANAB |
| NKTRNektar Therapeutics | 40.26 | +0.88% | $1.37B | vs ANAB |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs ANAB |
| KLRAKailera Therapeutics Inc. | 10.53 | -2.77% | $1.37B | vs ANAB |
| OMEROmeros Corporation | 18.75 | +1.30% | $1.36B | vs ANAB |
Indexes, lists and sector
Largest Health Care stocks
AnaptysBio stock FAQ
What is AnaptysBio's stock price today?
ANAB last traded at $45.65 as of Oct 7, 4:00 PM EDT, down 4.68% on the day. Prices are delayed at least 15 minutes.
When is AnaptysBio's next earnings date?
AnaptysBio is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.41.
What is the ANAB 52-week high?
The 52-week high for ANAB is $72.36 and the 52-week low is $20.18. The stock is currently 36.9% below its high.